agn-195263
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jul 1, 2012 (NCT01633788)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- agn-195263
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02965846 | Phase 3 | Dec 13, 2016 | Allergan |
| NCT02815293 | Phase 3 | Sep 30, 2016 | Allergan |
| NCT01633788 | Phase 2 | Jul 1, 2012 | Allergan |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allergan | For profit | 3 | 3 | 2 | 2012 |
1 organizations
Page 1 / 1